Over the last couple of years, we’ve heard a slew of anecdotal reports claiming NAD+ IVs provide a variety of significant benefits (Link). What about consumer experiences with the new Nicotinamide Riboside “NR” (FAQs) (Reviews) IV? Here’s a frank, first person account from Bill Walker (also an oral NR consumer):
Month: September 2024
While we mostly focus here on oral vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews), there’s growing demand for raising NAD levels through NAD+ IVs. And, if you happen to be one of those who enjoy NAD+ IVs, you now have what might be a better alternative: Niagen+ (NR) IVs, which deliver NAD+ booster Nicotinamide Riboside “NR”. Whats the case for Niagen+ (NR) IVs over NAD+ IVs? Below are results of a clinical study comparing Niagen+ (NR) IVs and NAD+ IVs followed by related comments from Chromadex CEO Rob Fried (seller of Niagen+ (NR) IVs) at an August investor conference:
As we await clinical trial results to confirm individual claims about NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews), we’re always interested to see if there are any consistencies in consumer anecdotal reports. Today, we hear from Coach Beede who posted the following earlier today (reposted here with permission):
This is not the first time we’ve heard from someone claiming that vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews) helped treat psoriasis. Gary Varvaro told us the same (Link). Some might find these claims plausible considering we’ve also heard from many others reporting remarkable skin benefits after taking NR (Link). Of course, until we have positive results from human clinical trials, we won’t know whether these claims have any credibility. That said, here is yet another powerful personal experience submitted to us by NR consumer Lawrence Lane:
We all know someone suffering from Long COVID. And, if you’re like me, you’ve been waiting patiently for results of the Harvard/MGH Long COVID clinical study (Details) evaluating NAD+ boosting supplement Nicotinamide Riboside “NR” (FAQs) (Life Changing Anecdotes) as a possible treatment. So, what’s the status of the study? Chromadex CEO Rob Fried explained during an investor presentation at the end of August: